Insider Transactions in Q3 2021 at Keros Therapeutics, Inc. (KROS)
Insider Transaction List (Q3 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 27
2021
|
Julius Knowles |
SELL
Open market or private sale
|
Indirect |
95,302
-3.82%
|
$3,907,382
$41.44 P/Share
|
|
Aug 17
2021
|
Jennifer Lachey Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,293
+1.49%
|
$0
$0.3 P/Share
|
|
Jul 02
2021
|
Julius Knowles |
SELL
Open market or private sale
|
Indirect |
23,818
-1.35%
|
$976,538
$41.4 P/Share
|
|
Jul 01
2021
|
Julius Knowles |
SELL
Open market or private sale
|
Indirect |
23,834
-0.87%
|
$977,194
$41.95 P/Share
|